Form D · Pharmaceuticals

Medicenna Therapeutics Inc.

Vancouver, A1 · CIK 0001672726

Offering snapshot reported Dec 19, 2016 · SEC filing

Reported sold: $742K
Investors reported: 1
Minimum accepted: $0
First sale: Apr 5, 2016

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$798,336 → $741,809

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Dec 19, 2016	Amendment	$741,809	-$56,527vs Apr 21, 2016	1	SEC filing
Apr 21, 2016	Initial	$798,336	No comparison	1	SEC filing

Offering details

Securities: Equity, Option to acquire, Other
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-261759

In April 2016, 399,168 special warrants were sold at a price per special warrant of CAD $2.00. In a second closing in December 2016, an additional 97,974 special warrants were sold at a price per special warrant of CAD $2.00.

Warrants exercisable into equity.

Source: Form D, filed Dec 19, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Fahar Merchant	Director, Executive
Rosemina Merchant	Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:

439 Helmcken Street
Vancouver, A1, V6B 2E6